Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer

Radiation Oncology

Shankar Siva¹  Xenia Ray²  Kevin L. Moore²  David Pryor³  Farshad Foroudi⁴  Nicholas Hardcastle⁵  Tomas Kron⁵  Alisha Moore⁶  Olivia Cook⁶  Alana Rossi⁶ 

[1] Department of Oncology, Sir Peter MacCallum, University of Melbourne, Parkville, Australia;Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia;Department of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, USA;Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia;Olivia Newton, John Cancer Centre at Austin Health, Heidelberg, Australia;Physical Sciences, Peter MacCallum Cancer Centre, 305 Grattan St, 3000, Melbourne, VIC, Australia;Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia;Department of Oncology, Sir Peter MacCallum, University of Melbourne, Parkville, Australia;Trans Tasman Radiation Oncology Group, Newcastle, Australia;

关键词: SABR;    SBRT;    Kidney;    Knowledge based planning;    Clinical trial;    Quality assurance;    Renal cell carcinoma;   

DOI  :  10.1186/s13014-021-01820-7

来源: Springer

【 授权许可】

CC BY